CGRP inhibitors provide new options for migraine treatment
Based on that research, the U.S. Food and Drug Administration (FDA) has approved two different types of migraine therapies targeting CGRP. The first CRGP inhibitors were designed as preventive therapy to reduce both the frequency and severity of migraine attacks. Since then, the FDA has also approved drugs to help stop or greatly reduce the symptoms of an acute headache. Here's what you should know if you're considering trying CGRP inhibitors.
Can CBD oil help manage pain?
Mpox is back: What to know and do
In 2022, the largest known outbreak spread to nearly 100,000 people in more than 100 countries. Now, a new outbreak of mpox has put it back in the news. What should you know — and do — about this latest international health emergency?
Meeting nutrient needs on a plant-based diet
Reorganize your kitchen: 6 hacks to help you lose weight and keep it off
Planning a plant-based diet
Chronic loneliness linked to higher risk of stroke
In a 2024 study by Harvard researchers, people who reported feeling persistently lonely had a 56% higher risk of experiencing a stroke compared with people who did not report feelings of loneliness.
High lipoprotein(a) raises heart attack risk even in healthy people
High levels of lipoprotein(a), or Lp(a)—a variant of LDL (bad) cholesterol— may triple the risk of a heart attack, even among healthy people with no other known risks for heart disease.
Study links Mediterranean diet to living longer
Following a Mediterranean eating pattern is linked to longer life—a finding at least partly explained by such heart-related improvements as decreases in body mass index, inflammation, triglyceride-rich lipoproteins, and insulin resistance.